|
1
|
Ponten J, Adami HO, Bergström R, Dillner
J, Friberg LG, Guftafsson L, Miller AB, Parkin DM, Sparén P and
Trichopoulos D: Strategies for global control of cervical cancer.
Int J Cancer. 60:1–26. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nair P, Nair MK, Jayaprakash PG and Pillai
MR: Decreased programmed cell death in the uterine cervix
associated with high risk human papilloma virus infection. Pathol
Oncol Res. 5:95–103. 1999. View Article : Google Scholar
|
|
3
|
Madrigal M, Janicek MF, Sevin BU, Perras
J, Estape R, Peñalver M and Averette HE: In vitro antigene therapy
targeting HPV-16 E6 and E7 in cervical carcinoma. Gynecol Oncol.
64:18–25. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harley BC and Sherwood WS: Telomerase,
checkpoints and cancer. Cancer Surv. 29:263–284. 1997.PubMed/NCBI
|
|
5
|
Johnstone RW, Ruefli AA and Lowe SW:
Apoptosis: A link between cancer genetics and chemotherapy. Cell.
108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dean M, Fojo T and Bates S: Tumor stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stassi G, Todaro M, Zerilli M,
Ricci-Vitiani L, Di Liberto D, Patti M, Florena A, Di Gaudio F, Di
Gesù G and De Maria R: Thyroid cancer resistance to
chemotherapeutic drugs via autocrine production of interleukin-4
and interleukin-10. Cancer Res. 63:6784–6790. 2003.PubMed/NCBI
|
|
8
|
Todaro M, Zerilli M, Ricci-Vitiani L, Bini
M, Perez Alea M, Maria Florena A, Miceli L, Condorelli G, Bonventre
S, Di Gesù G, et al: Autocrine production of interleukin-4 and
interleukin-10 is required for survival and growth of thyroid
cancer cells. Cancer Res. 66:1491–1499. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Conticello C, Pedini F, Zeuner A, Patti M,
Zerilli M, Stassi G, Messina A, Peschle C and De Maria R: IL-4
protects tumor cells from anti-CD95 and chemotherapeutic agents via
up-regulation of antiapoptotic proteins. J Immunol. 172:5467–5477.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dancescu M, Rubio-Trujillo M, Biron G,
Bron D, Delespesse G and Sarfati M: Interleukin 4 protects chronic
lymphocytic leukemic B cells from death by apoptosis and
upregulates Bcl-2 expression. J Exp Med. 176:1319–1326. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan J, Li R, Zhang R, Liu HL, Zhang N,
Zhang FQ and Dou KF: Effect of Bcl2 and Bax on survival of side
population cells from hepatocellular carcinoma cells. World J
Gastroenterol. 13:6053–6059. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park JR, Kim RJ, Lee YK, Kim SR, Roh KJ,
Oh SH, Kong G, Kang KS and Nam JS: Dysadherin can enhance
tumorigenesis by conferring properties of stemlike cells to
hepatocellular carcinoma cells. J Hepatol. 54:122–131. 2011.
View Article : Google Scholar
|
|
13
|
Shimamura T, Yasuda J, Ino Y, Gotoh M,
Tsuchiya A, Nakajima A, Sakamoto M, Kanai Y and Hirohashi S:
Dysadherin expression facilitates cell motility and metastatic
potential of human pancreatic cancer cells. Cancer Res.
64:6989–6995. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ståhlberg A, Zoric N, Åman P and Kubista
M: Quantitative real-time PCR for cancer detection: The lymphoma
case. Expert Review of Molecular Diagnostics. 5:221–230. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi Y, Fu X, Hua Y, Han Y, Lu Y and Wang
J: The side population in human lung cancer cell line NCI-H460 Is
enriched in stem-like cancer cells. PLoS One. 7:e333582012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer celllines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ravi D, Ramdas K, Mathew BS, Nalinakumari
KR, Nair MK and Pillai MR: Angiogenesis during tumor progression in
the oral cavity is related to reduced apoptosis and high tumor cell
proliferation. Oral Oncol. 34:543–548. 1998. View Article : Google Scholar
|
|
18
|
Todaro M, Alea MP, Di Stefano AB,
Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G,
Medema JP and Stassi G: Colon cancer stem cells dictate tumor
growth and resist cell death by production of interleukin-4. Cell
Stem Cell. 1:389–402. 2007. View Article : Google Scholar
|
|
19
|
Grunewald SM, Werthmann A, Schnarr B,
Klein CE, Bröcker EB, Mohrs M, Brombacher F, Sebald W and Duschl A:
An antagonistic IL-4 mutant prevents type I allergy in the mouse:
Inhibition of the IL-4/IL-13 receptor system completely abrogates
humoral immune response to allergen and development of allergic
symptoms in vivo. J Immunol. 160:4004–4009. 1998.PubMed/NCBI
|
|
20
|
Phillips HS, Kharbanda S, Chen R, Forrest
WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, et
al: Molecular subclasses of high-grade glioma predict prognosis,
delineate a pattern of disease progression, and resemble stages in
neurogenesis. Cancer Cell. 9:157–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eramo A, Ricci-Vitiani L, Zeuner A,
Pallini R, Lotti F, Sette G, Pilozzi E, Larocca LM, Peschle C and
De Maria R: Chemotherapy resistance of glioblastoma stem cells.
Cell Death Differ. 13:1238–1241. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kieslinger M, Woldman I, Moriggl R,
Hofmann J, Marine JC, Ihle JN, Beug H and Decker T: Antiapoptotic
activity of Stat5 required during terminal stages of myeloid
differentiation. Genes Dev. 14:232–244. 2000.PubMed/NCBI
|
|
23
|
Morrison BW and Leder P: A receptor
binding domain of mouse interleukin-4 defined by a solid-phase
binding assay and in vitro mutagenesis. J Biol Chem.
267:11957–11963. 1992.PubMed/NCBI
|
|
24
|
Gooch JL, Christy B and Yee D: STAT6
mediates interleukin-4 growth inhibition in human breast cancer
cells. Neoplasia. 4:324–331. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roca H, Craig MJ, Ying C, Varsos ZS,
Czarnieski P, Alva AS, Hernandez J, Fuller D, Daignault S, Healy PN
and Pienta KJ: IL-4 induces proliferation in prostate cancer PC3
cells under nutrient-depletion stress through the activation of the
JNK-pathway and survivin upregulation. J Cell Biochem.
113:1569–1580. 2012.
|
|
26
|
Joshi BH, Leland P, Lababidi S, Varrichio
F and Puri RK: Interleukin-4 receptor alpha overexpression in human
bladder cancer correlates with the pathological grade and stage of
the disease. Cancer Med. 3:1615–1628. 2014. View Article : Google Scholar : PubMed/NCBI
|
